Multi-omics analysis of human right atrial tissue ıdentifies molecular signatures of remodeling in tricuspid regurgitation.
4 affiliations
- 1Department of Cardiovascular Surgery, Hacettepe University Faculty of Medicine, Ankara, Türkiye. [email protected].
- 2Department of Cardiovascular Surgery, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
- 3Department of Biochemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Türkiye.
- 4Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Türkiye.
Abstract
Background Tricuspid regurgitation (TR) is associated with adverse clinical outcomes, yet the underlying right atrial (RA) molecular remodeling remains poorly understood. We aimed to define TR-associated RA remodeling using metabolomic and lipidomic profiling of human RA tissue. Methods RA appendage tissue was obtained intraoperatively from 24 adults undergoing cardiac surgery (11 with ≥severe TR; 13 controls). Gas chromatography mass spectrometry (GC-MS) was used for targeted small-molecule metabolomics, and liquid chromatography quadrupole time of flight mass spectrometry (LC-qTOF-MS) for untargeted lipidomics. Mann Whitney U testing, principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), and variable importance in projection (VIP) scoring were used to identify discriminatory multi-omics patterns between groups. Results Patients with TR demonstrated a distinct metabolic phenotype characterized by reduced glycolysis-related intermediates (glucose-6-phosphate, β-alanine, α-glucosamine-1-phosphate; all p < 0.05) and metabolites consistent with oxidative stress and amino acid catabolism markers (6-hydroxycaproic acid, porphine, phosphoric acid; all p < 0.05). Lipidomic analysis revealed broad phospholipid remodeling and signals consistent with mitochondrial-associated alterations, including a decreased phosphatidylcholine/phosphatidylethanolamine (PC/PE) ratio and reductions in selected diacylglycerol and ceramide species. PCA and PLS-DA demonstrated clear group separation with consistent VIP signals, indicating consistent multi-omics discrimination. Conclusions TR is associated with coordinated metabolic and lipidomic reprogramming in the RA, a pattern compatible with, though not direct evidence of, mitochondrial stress, impaired bioenergetics, and membrane destabilization. These findings support a model in which RA remodeling is tightly linked to TR pathophysiology, highlighting candidate molecular features for future validation. Multi-omics biomarkers may enhance risk stratification, inform the timing of intervention, and guide the development of future point-of-care molecular diagnostics. Graphical Abstract Severe tricuspid regurgitation leads to chronic right atrial volume and pressure overload, resulting in progressive right atrial remodeling. Tissue-based metabolomic and lipidomic analyses demonstrate a coordinated pattern of metabolic and lipid alterations, including reduced glycolytic intermediates, altered amino acid metabolism, and disrupted phospholipid and cardiolipin homeostasis, that is compatible with, but does not directly demonstrate, impaired mitochondrial energy metabolism. These molecular alterations are associated with adverse structural and functional consequences, including right atrial enlargement, increased right ventricular end-diastolic dimensions, reduced tricuspid annular plane systolic excursion, and right ventricle–pulmonary artery uncoupling. Collectively, these findings support the concept of an active, biologically driven right atrial cardiomyopathy that may contribute to heterogeneous postoperative recovery and inform future biomarker guided risk stratification and surgical timing.
Related
- Molecular signatures of bone remodeling imbalance in type 2 diabetes and osteoporosis comorbidity: a multi-omics study with in vivo support
- Metabolic Remodeling in Peritoneal Dialysis-Associated Peritoneal Fibrosis: Mechanisms, Candidate Metabolic Signatures, and Therapeutic Perspectives
- STRUCTURAL AND MOLECULAR DYNAMICS ANALYSIS OF HUMAN β-DEFENSIN 1 VARIANTS REVEALS DISTINCT PERTURBATION SIGNATURES
- Antipsychotic-Induced Remodeling of the Gut Microbiota: Drug-Specific Patterns and Molecular Links to Metabolic Adverse Effects.
- XYcellAtlas: a cell-type- and spatial-resolved pan-cancer atlas of sex-biased and Y chromosome loss-associated molecular signatures
BibTeX
@article{alma2026multiomics,
title = {{Multi-omics analysis of human right atrial tissue ıdentifies molecular signatures of remodeling in tricuspid regurgitation.}},
author = {Melih Alma and Ahmet Aydın and Aysima Sezer and Sevilay Erdoğan Kablan and İpek Baysal and Emirhan Nemutlu and Samiye Yabanoğlu Çiftçi and Mustafa Yılmaz},
journal = {BMC cardiovascular disorders},
year = {2026},
month = jul,
doi = {10.1186/s12872-026-06320-8},
url = {https://europepmc.org/article/MED/42907763},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Multi-omics analysis of human right atrial tissue ıdentifies molecular signatures of remodeling in tricuspid regurgitation.
AU - Melih Alma
AU - Ahmet Aydın
AU - Aysima Sezer
AU - Sevilay Erdoğan Kablan
AU - İpek Baysal
AU - Emirhan Nemutlu
AU - Samiye Yabanoğlu Çiftçi
AU - Mustafa Yılmaz
PY - 2026
DA - 2026/07/01
JO - BMC cardiovascular disorders
DO - 10.1186/s12872-026-06320-8
UR - https://europepmc.org/article/MED/42907763
AB - Background Tricuspid regurgitation (TR) is associated with adverse clinical outcomes, yet the underlying right atrial (RA) molecular remodeling remains poorly understood. We aimed to define TR-associated RA remodeling using metabolomic and lipidomic profiling of human RA tissue. Methods RA appendage tissue was obtained intraoperatively from 24 adults undergoing cardiac surgery (11 with ≥severe TR; 13 controls). Gas chromatography mass spectrometry (GC-MS) was used for targeted small-molecule metabolomics, and liquid chromatography quadrupole time of flight mass spectrometry (LC-qTOF-MS) for untargeted lipidomics. Mann Whitney U testing, principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), and variable importance in projection (VIP) scoring were used to identify discriminatory multi-omics patterns between groups. Results Patients with TR demonstrated a distinct metabolic phenotype characterized by reduced glycolysis-related intermediates (glucose-6-phosphate, β-alanine, α-glucosamine-1-phosphate; all p < 0.05) and metabolites consistent with oxidative stress and amino acid catabolism markers (6-hydroxycaproic acid, porphine, phosphoric acid; all p < 0.05). Lipidomic analysis revealed broad phospholipid remodeling and signals consistent with mitochondrial-associated alterations, including a decreased phosphatidylcholine/phosphatidylethanolamine (PC/PE) ratio and reductions in selected diacylglycerol and ceramide species. PCA and PLS-DA demonstrated clear group separation with consistent VIP signals, indicating consistent multi-omics discrimination. Conclusions TR is associated with coordinated metabolic and lipidomic reprogramming in the RA, a pattern compatible with, though not direct evidence of, mitochondrial stress, impaired bioenergetics, and membrane destabilization. These findings support a model in which RA remodeling is tightly linked to TR pathophysiology, highlighting candidate molecular features for future validation. Multi-omics biomarkers may enhance risk stratification, inform the timing of intervention, and guide the development of future point-of-care molecular diagnostics. Graphical Abstract Severe tricuspid regurgitation leads to chronic right atrial volume and pressure overload, resulting in progressive right atrial remodeling. Tissue-based metabolomic and lipidomic analyses demonstrate a coordinated pattern of metabolic and lipid alterations, including reduced glycolytic intermediates, altered amino acid metabolism, and disrupted phospholipid and cardiolipin homeostasis, that is compatible with, but does not directly demonstrate, impaired mitochondrial energy metabolism. These molecular alterations are associated with adverse structural and functional consequences, including right atrial enlargement, increased right ventricular end-diastolic dimensions, reduced tricuspid annular plane systolic excursion, and right ventricle–pulmonary artery uncoupling. Collectively, these findings support the concept of an active, biologically driven right atrial cardiomyopathy that may contribute to heterogeneous postoperative recovery and inform future biomarker guided risk stratification and surgical timing.
SN - 1471-2261
ER -